CD4+CD25+FOXP3+ regulatory T cells in nonhuman primates

Transplantation Reviews

Volumn 20, Issue 3, 2006, Pages 121-125

  Bloom, Debra D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALLOANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIPEPTIDYL PEPTIDASE IV; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MONOCLONAL ANTIBODY; OKT 3; POLYCLONAL ANTIBODY; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ALLOIMMUNITY; ANTIGEN PURIFICATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CLONAL ANERGY; DENDRITIC CELL; EFFECTOR CELL; FLOW CYTOMETRY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; KIDNEY TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTOPENIA; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; PRIMATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE;

EID: 33747807275     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2006.06.004     Document Type: Article

References (38)

1. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
2. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 6 (2005) 338-344
3. Wing K., Fehervari Z., and Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol (2006)
4. Estes J.D., Li Q., Reynolds M.R., et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193 (2006) 703-712
5. Chen W. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front Biosci 11 (2006) 1360-1370
6. Mellor A. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 338 (2005) 20-24
7. Curotto de Lafaille M.A., Lino A.C., Kutchukhidze N., and Lafaille J.J. CD25- T cells generate CD25+ Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173 (2004) 7259-7268
8. Li L., Godfrey W.R., Porter S.B., et al. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106 (2005) 3068-3073
9. Earle K.E., Tang Q., Zhou X., et al. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 115 (2005) 3-9
10. Masteller E.L., Warner M.R., Tang Q., et al. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 175 (2005) 3053-3059
11. Cava A.L., Kaer L.V., and Fu D.S. CD4(+)CD25(+) Tregs and NKT cells: regulators regulating regulators. Trends Immunol (2006)
12. Fields M.L., Hondowicz B.D., Metzgar M.H., et al. CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J Immunol 175 (2005) 4255-4264
13. Lim H.W., Hillsamer P., Banham A.H., et al. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 175 (2005) 4180-4183
14. Baecher-Allan C., Brown J.A., Freeman G.J., et al. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167 (2001) 1245-1253
15. Cao D., Malmstrom V., Baecher-Allan C., et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33 (2003) 215-223
16. Seddiki N., Santner-Nanan B., Tangye S.G., et al. Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107 (2006) 2830-2838
17. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
18. Yagi H., Nomura T., Nakamura K., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 16 (2004) 1643-1656
19. Muthukumar T., Dadhania D., Ding R., et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353 (2005) 2342-2351
20. Game D.S., Hernandez-Fuentes M.P., Chaudhry A.N., et al. CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients. J Am Soc Nephrol 14 (2003) 1652-1661
21. Salama A.D., Najafian N., Clarkson M.R., et al. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14 (2003) 1643-1651
22. Torrealba J.R., Katayama M., Fechner Jr. J.H., et al. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol 172 (2004) 5753-5764
23. Nashan B. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review. BioDrugs 19 (2005) 39-46
24. Renders L., and Valerius T. Engineered CD3 antibodies for immunosuppression. Clin Exp Immunol 133 (2003) 307-309
25. Asiedu C.K., Dong S.S., Lobashevsky A., et al. Tolerance induced by anti-CD3 immunotoxin plus 15-deoxyspergualin associates with donor-specific indirect pathway unresponsiveness. Cell Immunol 223 (2003) 103-112
26. Fechner Jr. J.H., Vargo D.J., Geissler E.K., et al. Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Transplantation 63 (1997) 1339-1345
27. Knechtle S.J. Treatment with immunotoxin. Philos Trans R Soc Lond B Biol Sci 356 (2001) 681-689
28. Thomas J.M., Eckhoff D.E., Contreras J.L., et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 69 (2000) 2497-2503
29. Calne R., Moffatt S.D., Friend P.J., et al. Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Nippon Geka Gakkai Zasshi 101 (2000) 301-306
30. Knechtle S.J., Pirsch J.D., Fechner H., et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 3 (2003) 722-730
31. Knechtle S.J., Fernandez L.A., Pirsch J.D., et al. Campath-1H in renal transplantation: the University of Wisconsin experience. Surgery 136 (2004) 754-760
32. Neujahr D.C., Chen C., Huang X., et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 176 (2006) 4632-4639
33. Pearl J.P., Parris J., Hale D.A., et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 5 (2005) 465-474
34. Wu Z., Bensinger S.J., Zhang J., et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 10 (2004) 87-92
35. Kirk A.D., Hale D.A., Mannon R.B., et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76 (2003) 120-129
36. Knechtle S.J., Vargo D., Fechner J., et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 63 (1997) 1-6
37. Gavin M.A., Clarke S.R., Negrou E., et al. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 3 (2002) 33-41
38. Vanasek T.L., Nandiwada S.L., Jenkins M.K., et al. CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol 176 (2006) 5880-5889